AUROVELA 1.5/30 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aurovela 1.5/30, and what generic alternatives are available?
Aurovela 1.5/30 is a drug marketed by Aurobindo Pharma and is included in one NDA.
The generic ingredient in AUROVELA 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AUROVELA 1.5/30?
- What are the global sales for AUROVELA 1.5/30?
- What is Average Wholesale Price for AUROVELA 1.5/30?
Summary for AUROVELA 1.5/30
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Patent Applications: | 130 |
DailyMed Link: | AUROVELA 1.5/30 at DailyMed |
Pharmacology for AUROVELA 1.5/30
Drug Class | Estrogen Progestin |
Mechanism of Action | Estrogen Receptor Agonists |
US Patents and Regulatory Information for AUROVELA 1.5/30
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma | AUROVELA 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 207581-001 | Jun 26, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |